InsidersTradesSigma
PAVmed Inc.: directors' dealings · United States · SEC (Form 4)
SEC:pavmed-inc-a5ecf0US·SEC (Form 4)Mcap 46M€Healthcare
Explore the full management transaction log of PAVmed Inc., a listed equity based in United States. Shares trade on US US, under the oversight of SEC (Form 4). Operating in the Healthcare sector, PAVmed Inc. has recorded 3 public disclosures. Market capitalisation: €46.2m. The latest transaction was reported on 11 April 2022 — Retenue fiscale. Among the most active insiders: Aklog Lishan. All data is free.
3
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
6.35 €
Analyst consensus
2 analysts16.00 €Target 40.50 €(+538%)65.00 €
Income statement
Revenue71 k€
Gross profit−147 k€-207% margin
Net income−3.8 M€564.8% margin
Valuation
PER (forward)-2.3x
P/Book0.6x
Beta0.64
Balance sheet & cash
Market cap46.2 M€
Total debt13.3 M€
Free Cash Flow−5.2 M€
Debt / Equity60%
Profitability & ownership
ROE-32.3%
ROA-39.2%
% insiders42.7%
% institutions9.9%
Last declaration on 11 April 2022
Declarations3 total
Executives●Retenue fiscale42SEC
€85,47679,636 shares@ €1.07330.19% mcap100.0% of flow
Common stock
SEC:0001062993-22-010063:0·
Executives●Retenue fiscale41SEC
€214,637199,973 shares@ €1.07330.46% mcap100.0% of flow
Common stock
SEC:0001062993-22-010064:0·
Executives●Retenue fiscale29SEC
€161,14575,000 shares@ €2.14860.35% mcap100.0% of flow
Common stock
SEC:0001062993-22-005565:0·
3 of 3 declarations